Primary and secondary outcomes were analysed on the ITT set with
no missing data for the primary criterion, i.e. 430 patients (220 in the
Fibrinogen group and 210 in the Placebo group)
Figure 2: Mean fibrinogen concentrations in Fibrinogen and
Placebo groups from baseline to D2 after study drug administration (ITT
set with no missing data for the primary criterion)